Strides Arcolab, announced that it has entered into a licensing agreement with Gilead Sciences Inc. (NASDAQ:GILD)under which Gilead has extended non-exclusive rights to Strides to manufacture and distribute Tenofovir Alafenamide (TAF), both as a single agent product and in combination with other drugs. Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin is 45.40% and weekly performance is 5.92%. On last trading … Continue reading Ever Green Stocks: Gilead Sciences Inc. (NASDAQ:GILD), Delta Air Lines (NYSE:DAL), Central Garden & Pet Company (NASDAQ:CENT), Safeway (NYSE:SWY), Nomura (NYSE:NMR)